All Stories

  1. A Fast Nonparametric Sampling (NPS) Method for Time-to-Event in Individual-Level Simulation Models.
  2. Using Age-Specific Rates for Parametric Survival Function Estimation in Simulation Models
  3. Value of Information: Success Stories
  4. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics
  5. Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program
  6. NordICC Trial Results in Line With Expected Colorectal Cancer Mortality Reduction After Colonoscopy: A Modeling Study
  7. Breastfeeding is associated with the intelligence of school‐age children in Mexico
  8. Cost effectiveness of non‐drug interventions that reduce nursing home admissions for people living with dementia
  9. Emulator-based Bayesian calibration of the CISNET colorectal cancer models
  10. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics
  11. A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
  12. Dynamics of Respiratory Infectious Diseases in Incarcerated and Free-Living Populations: A Simulation Modeling Study
  13. An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
  14. Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison
  15. Characterization and Valuation of the Uncertainty of Calibrated Parameters in Microsimulation Decision Models
  16. CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis
  17. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study
  18. Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico
  19. Age-specific rates of onset of cannabis use in Mexico
  20. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies
  21. Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study
  22. COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors
  23. Dependence of COVID-19 Policies on End-of-Year Holiday Contacts in Mexico City Metropolitan Area: A Modeling Study
  24. Prioritizing Research Informing Antibiotic Prophylaxis Guidelines for Knee Arthroplasty Patients
  25. BayCANN: Streamlining Bayesian Calibration With Artificial Neural Network Metamodeling
  26. Covid-19 Vaccine Acceptance in California State Prisons
  27. Outbreaks of Covid-19 Variants in Prisons: A Mathematical Modeling Analysis of Vaccination and Re-Opening Policies
  28. Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors
  29. Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
  30. How do Covid-19 policy options depend on end-of-year holiday contacts in Mexico City Metropolitan Area? A Modeling Study
  31. Age-Specific Rates of Onset of Cannabis Use in Mexico
  32. The Household Secondary Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Rapid Review
  33. A Summary of the 2020 Gastric Cancer Summit at Stanford University
  34. Estimating population-based recurrence rates of colorectal cancer over time in the United States
  35. Cost-effectiveness analysis of a multidisciplinary health-care model for patients with type-2 diabetes implemented in the public sector in Mexico: A quasi-experimental, retrospective evaluation
  36. Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
  37. Validation of Microsimulation Models Used for Population Health Policy
  38. Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers
  39. Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods
  40. Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies
  41. A Multidimensional Array Representation of State-Transition Model Dynamics
  42. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis
  43. Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio
  44. Midwife‐led care and obstetrician‐led care for low‐risk pregnancies: A cost comparison
  45. A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer
  46. A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management
  47. A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling
  48. A Multidimensional Array Representation of State-Transition Model Dynamics
  49. Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies
  50. “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier
  51. The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis
  52. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
  53. Nonidentifiability in model calibration and its implications for medical decision making.
  54. Revisiting assumptions about age-based sexual mixing representations in mathematical models
  55. Incorporating Biomarkers into the Primary Prostate Biopsy Setting: A Cost-Effectiveness Analysis
  56. Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model – CORRIGENDUM
  57. Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model
  58. Microsimulation modeling in R: A tutorial
  59. A Kinked Health Insurance Market: Employer-Sponsored Insurance under the Cadillac Tax
  60. A Gaussian Approximation to efficiently compute the expected value of sample information (EVSI)
  61. Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis
  62. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?
  63. An Overview of R in Health Decision Sciences
  64. Modeling the Cost-Effectiveness of Doula Care Associated with Reductions in Preterm Birth and Cesarean Delivery
  65. Análisis de costo-beneficio: prevención del VIH/sida en migrantes en Centroamérica
  66. Registro de señales de EEG para aplicaciones de Interfaz Cerebro Computadora (ICC) basado en Potenciales Evocados Visuales de Estado Estacionario (PEVEE)